CASTLE BIOSCIENCES, INC. (CSTL) Gross margin 2018–2025
CASTLE BIOSCIENCES, INC. (CSTL) gross margin by fiscal year — reported gross profit divided by reported revenue.
79.4%FY2025 · since FY2018: 76.8% → 79.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 79.4% | -2.5 pp |
| FY2024 | 81.9% | +2.3 pp |
| FY2023 | 79.5% | +2.9 pp |
| FY2022 | 76.6% | -6.5 pp |
| FY2021 | 83.2% | -1.4 pp |
| FY2020 | 84.5% | -1.4 pp |
| FY2019 | 85.9% | +9.2 pp |
| FY2018 | 76.8% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CSTL financial trends
CSTL RevenueCSTL Net incomeCSTL Net marginCSTL Gross profitCSTL Operating incomeCSTL Operating marginCSTL Operating cash flowCSTL Free cash flowCSTL Capital expendituresCSTL Return on equityCSTL Stock buybacksCSTL Dividends paidCSTL Total assetsCSTL Total liabilitiesCSTL Shareholders’ equityCSTL overview →